-
Orbit Genomics Partners With Icahn School of Medicine at Mount Sinai
We are thrilled to announce that Orbit Genomics has partnered with the esteemed Icahn School of Medicine at Mount Sinai for optimization of our revolutionary lung cancer diagnostic platform. This collaboration will allow us to further advance the accuracy and reliability of our test, which will have significant implications for the future of cancer diagnosis…
-
Orbit Genomics Raises $3 million To Launch Its Lung Cancer Diagnostic Test.
https://www.einpresswire.com/article/559943576/orbit-genomics-raises-3-million-to-launch-a-lung-cancer-diagnostic-test
-
Orbit Genomics was awarded a $250,000 Early Stage Capital and Retention Grant as part of Colorado Office of Economic Development and International Trade (OEDIT)’s Advanced Industries Accelerator Grant Program
https://oedit.colorado.gov/press-release/86-million-advanced-industries-awards-accelerate-36-colorado-start-ups